Acceptance and Commitment Therapy for Chronic Pain in SCI: Development and Testing of an eHealth Program

Sponsor
University of Michigan (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06098170
Collaborator
The Craig H. Neilsen Foundation (Other)
60
1
3
24
2.5

Study Details

Study Description

Brief Summary

This study will test the newly-developed My spinal cord injury (SCI) Toolkit program in two formats - unguided use of the program and use supported by a coach. These two active treatment formats will be compared to treatment as usual (waitlist control) in adults with chronic pain and SCI.

Hypotheses include:
  • Treatment adherence, participant satisfaction, and perception of positive change will be high and drop-out rates low for both treatments but will be better in the coached compared to the unguided arm

  • In terms of pre- to post-treatment changes in pain interference, coached My SCI Toolkit program will be superior to treatment as usual

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Unguided use of the My SCI Toolkit program
  • Behavioral: Coached My SCI Toolkit
N/A

Detailed Description

All participants will also be asked to complete online surveys at baseline (before being randomized to a group), half-way through the 8-week study period, and after the 8-week study period is over. The surveys are online and can be completed from home. Participants in the unguided and coached programs will also be asked to complete a weekly online survey asking about use of the website in the past week, taking approximately 5 minutes to complete.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Participants will be enrolled and randomized 1:1:1 to receive unguided use of the My SCI Toolkit program (number (n)=20), coached My SCI Toolkit (n=20) or wait-list control (n=20; treatment as usual) for an 8-week treatment period.Participants will be enrolled and randomized 1:1:1 to receive unguided use of the My SCI Toolkit program (number (n)=20), coached My SCI Toolkit (n=20) or wait-list control (n=20; treatment as usual) for an 8-week treatment period.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Acceptance and Commitment Therapy for Chronic Pain in SCI: Development and Testing of an eHealth Program
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2025
Anticipated Study Completion Date :
Oct 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Unguided use of the My SCI Toolkit program

Behavioral: Unguided use of the My SCI Toolkit program
Participants will be asked to use the My SCI Toolkit program for 8 weeks (without a coach), following the prompts and guides built into the program.

Experimental: Coached My SCI Toolkit

Behavioral: Coached My SCI Toolkit
Participants will be asked to use the My SCI Toolkit program for 8 weeks, following the prompts and guides built into the program. Participants will also have weekly phone calls (the first is about 30-45 minutes, and the rest are about 15 minutes) with a study coach. The coach can help answer questions and tailor the skills more to the participant's goals and needs. The coaching sessions will be audio recording for fidelity purposes.

No Intervention: Wait-list control

Participants will not access the My SCI Toolkit program during the 8-week study period and will be asked to continue daily life, including management of pain, as usual.

Outcome Measures

Primary Outcome Measures

  1. Percent of participants in each arm that dropped out of the study [8 weeks]

  2. Number of days/week that My SCI Toolkit was accessed [8 weeks]

  3. Number of minutes/week spent on the My SCI Toolkit website [8 weeks]

  4. Participant Satisfaction Evaluation [8 weeks (post intervention)]

    This is a 12-question survey that participants answer with scores ranging from 1-4. The total scores range from 12-48 with a higher score meaning more satisfaction.

  5. Patient Global Impression of Change (PGIC) [8 weeks (post intervention)]

    This is a one question scale that participants select from no change (1) to a great deal better (7).

  6. Change in SCI-QOL Pain Interference Short Form [Baseline, 8 weeks (post intervention)]

    This is a 10-question survey that participants answer from not at all (1) to very much (5). Scores are on a T-score metric with Mean=50, Standard Deviation=10. A higher score means more interference.

Secondary Outcome Measures

  1. Change in Patient Reported Outcomes Measurement Information System (PROMIS) Pain Intensity Short Form [Baseline, 8 weeks (post intervention)]

    This is a 3-question survey that is scored on a T-score metric with Mean=50, Standard Deviation=10. A higher score means higher pain intensity.

  2. Change in SCI-QOL Pain Behavior Short Form [Baseline, 8 weeks (post intervention)]

    This survey has 7-questions. Three questions are answered never (1) to always (5) and 3 questions are answered had no pain (1) to always (6). Scores are on a T-score metric with a Mean=50, Standard Deviation=10. A higher score indicates more behavioral manifestations of pain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of SCI (all injury levels included);

  • Average pain intensity over the past 3 months greater or equal to (≥) 4/10 on 0-10 numerical rating scale

  • Fluent in English and able to read English at a 6th grade level

  • Access to internet connected device (phone, tablet, computer) and telephone

  • Willingness to maintain stable analgesic regimen during study period

Exclusion Criteria:
  • Currently in inpatient care or intensive outpatient physical therapy

  • Significant cognitive impairment as indicated by scores ≥2 on cognitive screener

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan
  • The Craig H. Neilsen Foundation

Investigators

  • Principal Investigator: Anna Kratz, PhD, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anna Kratz, Professor of Physical Medicine and Rehabilitation, University of Michigan
ClinicalTrials.gov Identifier:
NCT06098170
Other Study ID Numbers:
  • HUM00192610
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 24, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Anna Kratz, Professor of Physical Medicine and Rehabilitation, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 24, 2023